Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November GlobeNewswire October 30, 2025 SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will […]